Search

everythinglearnresearchcommunity

for

Search:↓

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Endocrine disruptors may cause early hair loss.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

In 1981, the punch graft technique was the main method for hair transplantation, and medical treatments for baldness were not very effective.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Substance P may worsen acne by increasing inflammation, but corticosteroids might help by reducing this effect.

Chronic stress can reduce skin pigmentation.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

New psoriasis treatments are effective but come with side effects and risks.

Some chemicals absorbed through the skin can cause serious health problems.

Some skin medications can harm male fertility, but they don't seem to cause birth defects from father's exposure.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

Taking a small dose of prednisone before menstruation can almost completely prevent premenstrual acne with few side effects.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

The document concludes that scalp disorders can be treated with hair washing, specific shampoos, medications, and sometimes surgery or hair transplants, but hereditary baldness is untreatable.

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

Stopping forehead irritation and using hydrocortisone helped a man's skin, Martinique has lower melanoma rates, a man had an allergy to a specific antifungal, another had unexplained cysts, certain drugs can cause skin reactions without always being interrelated, a link between Fanconi anemia and a skin condition was suggested, high levels of a certain protein may play a role in a type of psoriasis, and there's a need to study the connection between scalp pain and hair loss.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

A 16-year-old girl with autoimmune hemolytic anemia and deep vein thrombosis improved with treatment, possibly indicating systemic lupus erythematosus.

Vitamin D is crucial for health, and deficiency can cause hair loss and other health issues.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.